January 28, 2026
1 min read

Antheia seals 2nd series C funding close, hitting more than $175M in a year

Biosynthesis specialist Antheia has topped off its series C funding with a second close, adding $24 million more to its haul. The financing lift brings Antheia’s total funding over the past year to more than $175 million when combined with other capital and new contracts with the U.S. government, according to the company.

Leave a Reply

Your email address will not be published.

Previous Story

NotCo: How AI can help companies align innovation with new US dietary guidelines

Next Story

Cellares’ series D round draws $257M as cell therapy contractor takes operations global

Previous Story

NotCo: How AI can help companies align innovation with new US dietary guidelines

Next Story

Cellares’ series D round draws $257M as cell therapy contractor takes operations global

Latest from Blog

Go toTop